Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow the Sutures: Botox for Chronic Migraine
NCT03543254Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- May 2018
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in chronic migraine (CM), sponsored by Norwegian University of Science and Technology. Started May 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine (CM)
Beyond the preview
Go deeper on NCT03543254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03543254.